Anchor price 84.50 on closest trading day on/after 2025-03-06. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-20 | Quinlan Paul T | officer | Option exercise | 9,000 | $7.80 | $70K |
| 2026-10-20 | Quinlan Paul T | officer | Sale | 400 | $74.90 | $30K |
| 2026-10-20 | Quinlan Paul T | officer | Sale | 500 | $76.12 | $38K |
| 2026-10-20 | Quinlan Paul T | officer | Sale | 1,000 | $77.20 | $77K |
| 2026-10-20 | Quinlan Paul T | officer | Sale | 4,100 | $78.79 | $323K |
| 2026-10-20 | Quinlan Paul T | officer | Sale | 3,000 | $79.49 | $238K |
| 2026-10-01 | Klein Lawrence Otto | director, officer | Option exercise | 25,000 | $7.80 | $195K |
| 2026-10-01 | Klein Lawrence Otto | director, officer | Sale | 16,246 | $83.40 | $1.35M |
| 2026-10-01 | Klein Lawrence Otto | director, officer | Sale | 8,554 | $84.03 | $719K |
| 2026-10-01 | Klein Lawrence Otto | director, officer | Sale | 200 | $84.78 | $17K |
| 2026-09-15 | Goncalves Joana | officer | Option exercise | 3,500 | $6.84 | $24K |
| 2026-09-15 | Goncalves Joana | officer | Option exercise | 3,500 | $7.80 | $27K |
| 2026-09-15 | Goncalves Joana | officer | Sale | 2,384 | $91.10 | $217K |
| 2026-09-15 | Goncalves Joana | officer | Sale | 3,150 | $92.03 | $290K |
| 2026-09-15 | Goncalves Joana | officer | Sale | 1,366 | $92.99 | $127K |
| 2026-09-15 | Goncalves Joana | officer | Sale | 100 | $94.22 | $9K |
| 2026-09-15 | Goncalves Joana | officer | Sale | 947 | $95.71 | $91K |
| 2026-09-15 | Agarwal Arjun | officer | Sale | 560 | $95.71 | $54K |
| 2026-09-15 | Klein Lawrence Otto | director, officer | Sale | 2,452 | $95.71 | $235K |
| 2026-09-15 | Quinlan Paul T | officer | Sale | 1,039 | $95.71 | $99K |
| 2026-09-15 | Sandler Laura Lee | officer | Sale | 906 | $95.71 | $87K |
| 2026-09-11 | Agarwal Arjun | officer | Option exercise | 8,000 | $12.50 | $100K |
| 2026-09-11 | Agarwal Arjun | officer | Option exercise | 1,459 | $34.39 | $50K |
| 2026-09-11 | Agarwal Arjun | officer | Sale | 3,000 | $91.11 | $273K |
| 2026-09-11 | Agarwal Arjun | officer | Sale | 4,051 | $92.41 | $374K |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-01 | SCHEDULE 13D/A | Fairmount Funds Management LLC | 19.50% | 14,553,895 | view → |
| 2022-07-08 | SC | Funicular Funds, LP | — | — | view → |
| 2022-04-14 | SC | Funicular Fund, LP | — | — | view → |
| 2022-04-04 | SC | Funicular Fund, LP | — | — | view → |
| 2018-03-05 | SC | Growth Equity Opportunities IV, LLC | — | — | view → |
| 2018-01-04 | SC | SABBY MANAGEMENT, LLC | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-10-15 | SCHEDULE 13D | Alaunos Therapeutics, Inc. | 19.99% | 858,789 | view → |
| 2026-10-09 | SCHEDULE 13D/A | SPYRE THERAPEUTICS, INC. | 9.99% | 9,354,200 | view → |
| 2026-09-11 | SCHEDULE 13D | Korsana Biosciences, Inc. | 19.99% | 9,103,729 | view → |
| 2026-09-03 | SCHEDULE 13D/A | Apogee Therapeutics, Inc. | — | 0 | view → |
| 2026-07-20 | SCHEDULE 13D/A | Crescent Biopharma, Inc. | — | 6,593,385 | view → |
| 2026-07-01 | SCHEDULE 13D/A | ORUKA THERAPEUTICS, INC. ORKA | 19.50% | 14,553,895 | view → |
| 2026-06-23 | SCHEDULE 13D/A | SPYRE THERAPEUTICS, INC. SYRE | — | 8,835,440 | view → |
| 2026-06-23 | SCHEDULE 13D/A | Apogee Therapeutics, Inc. APGE | 9.99% | 6,713,519 | view → |
| 2026-06-09 | SCHEDULE 13D/A | Jade Biosciences, Inc. JBIO | 19.99% | 14,069,494 | view → |
| 2026-05-13 | SCHEDULE 13D/A | Viridian Therapeutics, Inc.\DE VRDN | — | 17,201,800 | view → |
| 2026-01-22 | SCHEDULE | Cogent Biosciences, Inc. COGT | 9.90% | 16,261,918 | view → |
| 2026-01-22 | SCHEDULE | Apogee Therapeutics, Inc. APGE | 9.99% | 6,047,027 | view → |
| 2025-10-14 | SCHEDULE | Apogee Therapeutics, Inc. APGE | 9.99% | 5,776,881 | view → |
| 2025-09-15 | SCHEDULE | Dianthus Therapeutics, Inc. /DE/ DNTH | 9.90% | 4,052,052 | view → |
| 2024-04-01 | SC | Cogent Biosciences, Inc. COGT | — | — | view → |
| 2024-04-01 | SC | Dianthus Therapeutics, Inc. /DE/ DNTH | — | — | view → |
| 2024-04-01 | SC | Viridian Therapeutics, Inc.\DE VRDN | — | — | view → |
| 2024-04-01 | SC | Apogee Therapeutics, Inc. APGE | — | — | view → |
| 2023-12-11 | SC | Spyre Therapeutics, Inc. SYRE | — | — | view → |
| 2023-06-13 | SC | Cogent Biosciences, Inc. COGT | — | — | view → |
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →